nik-macmillan-280300.jpg

investors

 
 

STOCK INFORMATION

BlissCo is currently trading on the following stock exchanges:

Canadian Stock Exchange (CSE) as BlissCo Cannabis Corp. (BLIS)

Frankfurt Stock Exchange (FRA) as GQ4B:GR

 

BlissCo Ecosystem Continues Expansion: Signs Base Price and Profit Sharing Supply Agreement with GreenSeal

  • Agreement prepares BlissCo Ecosystem to supply the $63.5 billion global market

Not for distribution in the U.S. or to U.S. newswire services.

Vancouver, British Columbia – July 12, 2018 – BlissCo Cannabis Corp. (FRA: GQ4B) (CSE: BLIS), (“BlissCo”) is pleased to announce that is has signed an agreement with GreenSeal Cannabis Company Ltd. (“GreenSeal”), to purchase 1,700 kilos of dried cannabis and 340 kilos of trim in the first two years of the agreement. The agreement has two renewable one year options.

This agreement provides BlissCo with the ability to use GreenSeal’s dried cannabis and package, process and sell the cannabis product to BlissCo’s medical patients or adult recreational customers in Canada when it is legal or export medical cannabis to other countries where medical cannabis is federally legal.

“A key aspect of the development of the BlissCo Ecosystem is building strong industry relationships. We have built a strong relationship with GreenSeal over the last 15 months and are pleased to announce our long-term partnership to purchase premium bulk cannabis for sale to our medical patients or into the adult use market. The unique base price and profit sharing supply agreement will help BlissCo and GreenSeal mutually benefit and build strong ties that benefit both companies,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp.

In the spirit of collaborative partnerships our base price and profit sharing supply agreement with GreenSeal ensures that both companies will mutually benefit. When BlissCo earns amendments to our Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) licence for sale of cannabis, we will be able to process and package GreenSeal cannabis as BlissCo branded dried cannabis, cannabis oil or pre-rolls for the medical and adult use markets. As well, BlissCo can use GreenSeal cannabis to process and package concentrate pens and cannabis edibles (including beverages) when concentrates and edibles are regulated for sale.

“We are thrilled to have solidified our relationship with BlissCo through this unique agreement and feel this collaborative model demonstrates the innovative professionals now occupying this space. With BlissCo’s reach domestically and internationally, we feel this opens up exciting new opportunities for GreenSeal to provide Canadian-grown products to an evolving marketplace full of potential. We are confident that this is only the beginning of a long and prosperous relationship in which GreenSeal consistently provides Damian and his outstanding team with some of the finest cannabis products, genetics and expertise Canada has to offer,” said Corey Hamilton, President of GreenSeal Cannabis Company Ltd.  

According to research published by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016. The market is forecasted to reach a value of $63.5 billion in global sales in 2024.

 

About GreenSeal Cannabis Company Ltd.

GreenSeal Cannabis Company, Ltd. is a commercially-licensed producer under the ACMPR with a strong focus on developing premium quality cannabis products and genetics for the rapidly evolving global market – through its unique innovative platform, experienced team of professionals and vertical cultivation technology.

Based in Stratford, Ontario, GreenSeal is committed to ensuring the excellence of its products through research and innovation related to plant genetics, cultivation techniques and automation technology; ensuring the company both establishes and sustains itself as a valued leader within the modernizing cannabis industry.

“For the Greener Good”

 

About BlissCo Cannabis Corp.

BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B) is an ACMPR licensed producer and future distributor of ultra-premium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships.  

BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.

BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo's future patients and customers.

Learn more: BlissCo.com

 

On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

 

For further information please contact:

Ariel Jack Lewinski, Business Development & Investor Relations 

 1-604-377-7533

ariel.lewinski@blissco.com

 

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

See All Investor Updates

OUR COMPANY

As Canada is primed as a global leader and first mover in the cannabis industry, BlissCo is uniquely poised in the rapidly growing multi-billion dollar market and in various international markets as cannabis regulations progress.

BlissCo, founded in 2013, is a Canadian vertically integrated cultivation, extraction and distribution focused cannabis brand that earned its Access to Cannabis for Medical Purposes Regulations (ACMPR) license to cultivate from Health Canada on March 29, 2018.

BlissCo's state-of-the-art production facility, located in Metro Vancouver, is purposefully designed as a hub for research, cultivation, processing, extraction, packaging and distribution.

Now with the ACMPR license to cultivate, BlissCo will commence its operation to harvest premium cannabis within its' urban facility in Metro Vancouver.  BlissCo also has a multi-year supply agreement in place with a Canadian Licensed Producer of characteristically sun-grown premium medicinal cannabis to purchase supply in large volumes (news release). This premium bulk cannabis will be brought to our secure and pristine facility in British Columbia for processing and then be packaged for sale and distribution to our growing patient list when BlissCo has appropriately received its license for sale. 

BlissCo was founded with the assistance of a team of advisors, including medical and naturopathic doctors, has intentionally engaged with the medical community to understand how to contribute to improved patient health with medicinal cannabis products. A large part of our strategy for growth centres on how to securely integrate and collaborate with the healthcare system.

The BlissCo team has deep domain expertise in the critical category success areas:

  • Multi-province controlled substance distribution (BC and Alberta)
  • Cultivation and product safety, consistency and security
  • Indoor cultivation, controlled environments ensuring high standards &  consistent products.
  • Quality assurance, product safety, 3rd Party GMP Audits & Certifications.


Milestones

2018

February

Strategic partnership with the Supreme Cannabis Company

Trading on Canadian Securities Exchange (CSE:BLIS)

March
ACMPR License to Produce earned

May

Cannabis plant starting material to arrive at BlissCo's facility and growing commences. 

ACMPR Cannabis Oil Extraction License application submitted

June

Sign agreement to export 720 kilograms of medical cannabis to Germany

July

ACMPR License to Sell application submitted

Sign supply agreement with GreenSeal Cannabis

Sign e-commerce and technology service agreement with Namaste Technologies (TSXV: N) 

2017

February
Confirmation of Readiness for Inspection received from Health Canada

May
Confirmation of Readiness for License from Health Canada

August
Close on purchasing facility for $2.4m

September
Earn Building Permit from Township of Langley
Commence Construction

2014

July
ACMPR Licensed Submitted

 


Downloads and Links

BlissCo Cannabis Corp. CSE listing

BlissCo Cannabis Corp. Sedar filing information.

BlissCo logo

To learn more about investment opportunities please contact investors@blissco.com.